SCHEMBL23914064

SCHEMBL23914064

C=C1C(=O)O[C@H](c2ccccc2Br)[C@@H]1c1ccc(C#N)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 1/20 0.34
CYP19A1 P11511 1/20 0.34
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CASP1 P29466 1/20 0.31
CASP7 P55210 1/20 0.31
CXCR2 P25025 1/20 0.31
NPC1 O15118 1/20 0.31
RAB9A P51151 1/20 0.31
CDK1 P06493 1/20 0.31
MARK3 P27448 1/20 0.31
AXL P30530 1/20 0.31
CLK2 P49760 1/20 0.31
GSK3B P49841 1/20 0.31
CDK5 Q00535 1/20 0.31
MARK2 Q7KZI7 1/20 0.31
SLK Q9H2G2 1/20 0.31
CLK4 Q9HAZ1 1/20 0.31
TSHR P16473 1/20 0.30
MYB P10242 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23914317 0.82 MAOB (0.39) TNKSCYP19A1NPC1
SCHEMBL23913791 0.82 TNKS (0.40) TNKSCYP19A1KDM4EALDH1A1NPC1
SCHEMBL23914431 0.82 TNKS (0.40) TNKSCYP19A1KDM4EALDH1A1NPC1
SCHEMBL23913942 0.81 ALDH1A1 (0.38) CYP19A1KDM4EALDH1A1TSHR
SCHEMBL23914310 0.78 MAPK1 (0.37) TNKSCYP19A1ALDH1A1
SCHEMBL23913790 0.77 ALDH1A1 (0.46) TNKSCYP19A1ALDH1A1
SCHEMBL23913941 0.77 CA2 (0.46) TNKSCYP19A1
SCHEMBL23914279 0.77 ALDH1A1 (0.46) TNKSCYP19A1ALDH1A1
SCHEMBL23913787 0.74 KDM1A (0.46) ALDH1A1CASP1CASP7NPC1RAB9A
SCHEMBL23914347 0.73 HDAC4 (0.38) ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS PURDUE RESEARCH FOUNDATION (US) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317099-A1 SAFER, POTENT, AND FAST ACTING ANTIMICROBIAL AGENTS MIF, LTA, MGAM TNKS 556/4885CYP19A1 2911/4885KDM4E 2541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.